Market Forecast By Regions (North America, Latin America, Europe, Asia Pacific, Middle East and Africa), By Drug Class (Quinine, Chloroquine, Proguanil, Mefloquine, Pyrimethamine, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce & Other Distribution Channel) And Competitive Landscape
Product Code: ETC160029 | Publication Date: Feb 2022 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 300 | No. of Figures: 90 | No. of Tables: 30 |
The global antimalarial drugs market is witnessing increased investment in research and development projects. Pharmaceutical companies and governments are investing heavily in the development of new and more effective antimalarial drugs. Additionally, the global antimalarial drugs industry has also registered growing demand for combination therapies. Combination therapies that use two or more drugs are becoming increasingly popular in the treatment of malaria. These therapies have been shown to be more effective than single-drug therapies and can also help to prevent drug resistance. Moreover, new methods of delivering antimalarial drugs, such as injectable formulations and transdermal patches, are being developed to improve the effectiveness of treatment. Further, the stakeholders in the antimalarial drugs market, including governments, pharmaceutical companies, and non-governmental organizations, are collaborating more closely to develop new drugs and improve access to existing treatments.
The COVID-19 pandemic has had a significant impact on the antimalarial drugs market, with disruptions to supply chains and increased demand for certain drugs, such as hydroxychloroquine, which has been used to treat COVID-19 patients. Moreover, advancements in drug development technologies have led to the development of new and more effective antimalarial drugs. These drugs are able to target different stages of the malaria parasite's life cycle, making them more effective at preventing and treating the disease. Additionally, efforts to increase awareness of malaria and prevention measures, such as the use of insecticide-treated bed nets and indoor residual spraying, are reducing the incidence of malaria. However, these prevention efforts also drive demand for antimalarial drugs.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Antimalarial Drugs Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Antimalarial Drugs Market Revenues & Volume, 2020 & 2027F |
3.3 Global Antimalarial Drugs Market - Industry Life Cycle |
3.4 Global Antimalarial Drugs Market - Porter's Five Forces |
3.5 Global Antimalarial Drugs Market Revenues & Volume Share, By Regions, 2020 & 2027F |
3.6 Global Antimalarial Drugs Market Revenues & Volume Share, By Drug Class, 2020 & 2027F |
3.7 Global Antimalarial Drugs Market Revenues & Volume Share, By Distribution Channel, 2020 & 2027F |
4 Global Antimalarial Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Antimalarial Drugs Market Trends |
6 Global Antimalarial Drugs Market, 2017 - 2027 |
6.1 Global Antimalarial Drugs Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
6.2 Global Antimalarial Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
7 North America Antimalarial Drugs Market, 2017 - 2027 |
7.1 North America Antimalarial Drugs Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
7.2 North America Antimalarial Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
8 Latin America Antimalarial Drugs Market, 2017 - 2027 |
8.1 Latin America Antimalarial Drugs Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
8.2 Latin America Antimalarial Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
9 Europe Antimalarial Drugs Market, 2017 - 2027 |
9.1 Europe Antimalarial Drugs Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
9.2 Europe Antimalarial Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
10 Asia Pacific Antimalarial Drugs Market, 2017 - 2027 |
10.1 Asia Pacific Antimalarial Drugs Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
10.2 Asia Pacific Antimalarial Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
11 Middle East Antimalarial Drugs Market, 2017 - 2027 |
11.1 Middle East Antimalarial Drugs Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
11.2 Middle East Antimalarial Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
12 Africa Antimalarial Drugs Market, 2017 - 2027 |
12.1 Africa Antimalarial Drugs Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
12.2 Africa Antimalarial Drugs Market, Revenues & Volume, By Distribution Channel, 2017 - 2027 |
13 Global Antimalarial Drugs Market Key Performance Indicators |
14 Global Antimalarial Drugs Market - Opportunity Assessment |
14.1 Global Antimalarial Drugs Market Opportunity Assessment, By Regions, 2020 & 2027F |
14.2 Global Antimalarial Drugs Market Opportunity Assessment, By Drug Class, 2020 & 2027F |
14.3 Global Antimalarial Drugs Market Opportunity Assessment, By Distribution Channel, 2020 & 2027F |
15 Global Antimalarial Drugs Market - Competitive Landscape |
15.1 Global Antimalarial Drugs Market Revenue Share, By Companies, 2020 |
15.2 Global Antimalarial Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
16 Company Profiles |
17 Recommendations |
18 Disclaimer |